Octreotide Acetate 25021-0466
Product NDC
25021-0466- Manufacturer
- Sagent Pharmaceuticals
- Dosage Form
- Injection, Solution
- Route
- Intravenous And Subcutaneous
- Product Type
- Human Prescription Drug
- Marketing Start
- June 15, 2023
- Listing Expires
- December 31, 2026
- Application
- ANDA091041
Need to source Octreotide Acetate? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Octreotide Acetate | 200 ug/mL |
Drug Class
Somatostatin Analog [EPC]Somatostatin Receptor Agonists [MoA]
Packaging Options(1)
1 VIAL in 1 CARTON (25021-466-05) / 5 mL in 1 VIAL